Skip to main content
. 2015 Apr 18;6(18):15984–15994. doi: 10.18632/oncotarget.3762

Figure 6. MiR-622 shows a high expression in rectal cancer patients with non-regression after standard dose radiation therapy.

Figure 6

A. Relative expression of miR-622 in biopsies of 17 rectal cancer patients before any treatment. B. Analysis of miR-622 expression between patients without regression (TRG4) and partial/complete regression (TRG1-3). C. The role of miR-622 in radioresistance of colorectal cancer. RNU6B was an internal control for qRT-PCR. TRG = tumor regression grade.